Liquidia Technologies Inc(LQDA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

LQDA Liquidia Technologies Inc

休市中 10-23 16:00:00 EDT

42.65

+2.96

+7.46%

盘后42.36

-0.29-0.68%

19:58 EDT

最高42.83	最低38.69	成交量380.56万
今开39.86	昨收39.69	日振幅10.43%
总市值38.18亿	流通市值30.43亿	总股本8,951万
成交额1.58亿	换手率5.33%	流通股本7,136万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"LQDA","market":"US","secType":"STK","nameCN":"Liquidia Technologies Inc","latestPrice":42.65,"timestamp":1792785600000,"preClose":39.69,"halted":0,"volume":3805641,"hourTrading":{"tag":"盘后","latestPrice":42.36,"preClose":42.65,"latestTime":"19:58 EDT","volume":129229,"amount":5506742.81,"timestamp":1792799935318,"change":-0.29,"changeRate":-0.0068,"amplitude":0.020002},"delay":0,"changeRate":0.07457797933988412,"floatShares":71356853,"shares":89508891,"eps":1.4,"marketStatus":"休市中","change":2.96,"latestTime":"10-23 16:00:00 EDT","open":39.86,"high":42.83,"low":38.69,"amount":157929774.486183,"amplitude":0.104308,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":1.4,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1793001600000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1532577600000,"exchange":"NASDAQ","adjPreClose":39.69,"preHourTrading":{"tag":"盘前","latestPrice":39.99,"preClose":39.69,"latestTime":"09:29 EDT","volume":4908,"amount":194582.91156,"timestamp":1792762199001,"change":0.3,"changeRate":0.007559,"amplitude":0.024943},"postHourTrading":{"tag":"盘后","latestPrice":42.36,"preClose":42.65,"latestTime":"19:58 EDT","volume":129229,"amount":5506742.81,"timestamp":1792799935318,"change":-0.29,"changeRate":-0.0068,"amplitude":0.020002},"volumeRatio":1.0017781528927774,"impliedVol":0.7654,"impliedVolPercentile":0.004},"requestUrl":"/m/hq/s/LQDA","defaultTab":"news","newsList":[{"id":"2675325537","title":"美股异动 | 与美国联合医疗达成和解协议 Liquidia(LQDA.US)早盘大涨超25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2675325537","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675325537?lang=zh_cn&edition=full","pubTime":"2026-10-14 23:34","pubTimestamp":1791992087,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4532","BK4007","BK4139","LU1571399168.USD","UTHR","LU1699723380.USD","LQDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125870583","title":"美股异动｜Liquidia股价飙升40%，创2023年12月以来最大盘中涨幅","url":"https://stock-news.laohu8.com/highlight/detail?id=1125870583","media":"老虎快讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1125870583?lang=zh_cn&edition=full","pubTime":"2026-10-14 21:36","pubTimestamp":1791985010,"startTime":"0","endTime":"0","summary":"美国生物制药公司Liquidia股价飙升40%，创2023年12月以来最大盘中涨幅。","market":"other","thumbnail":"https://static.tigerbbs.com/edc98c04cdc47dd0d16e08274ce9a364","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/edc98c04cdc47dd0d16e08274ce9a364"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LQDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172077158","title":"异动解读｜Liquidia Technologies Inc盘中上涨34.22%，减持扰动消化后资金重估产品进展","url":"https://stock-news.laohu8.com/highlight/detail?id=1172077158","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1172077158?lang=zh_cn&edition=full","pubTime":"2026-10-14 21:31","pubTimestamp":1791984668,"startTime":"0","endTime":"0","summary":"10月14日，Liquidia Technologies Inc盘中上涨34.22%，报36.0美元/股，成交额1.38亿美元。消息面上，前期董事长经由Canaan LP减持带来的负面情绪有所钝化，资金重新聚焦Yutrepia适应症拓展与商业化放量。已披露信息显示，Stephen Bloch于10月5日以每股27.13美元出售235477股，套现约640万美元，相关主体持股降至零；但公司基本面方面，Yutrepia已获FDA快速通道资格，用于系统性硬化症相关雷诺现象，且二季度YUTREPIA净销售额约1.704亿美元，环比增长31%，反映市场更关注后续增长兑现。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Liquidia异动拉升，资金重估产品进展","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LQDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153857400","title":"异动解读｜Liquidia Technologies Inc盘前上涨48.45%，减持扰动消化后资金重估产品进展","url":"https://stock-news.laohu8.com/highlight/detail?id=1153857400","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1153857400?lang=zh_cn&edition=full","pubTime":"2026-10-14 16:02","pubTimestamp":1791964973,"startTime":"0","endTime":"0","summary":"10月14日，Liquidia Technologies Inc盘前上涨48.45%，报38.98美元/股，成交额40.93万美元。消息面上，前期董事长经由Canaan LP减持带来的负面情绪有所钝化，资金重新聚焦Yutrepia适应症拓展与商业化放量。已披露信息显示，董事长Stephen Bloch于10月5日以每股27.13美元出售235477股，套现约640万美元，相关主体持股降至零；但公司基本面方面，Yutrepia已获FDA快速通道资格，用于系统性硬化症相关雷诺现象，且二季度YUTREPIA净销售额约1.704亿美元，环比增长31%，反映市场更关注后续增长兑现。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"减持扰动消化，Liquidia盘前大涨","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LQDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100103077","title":"异动解读｜Liquidia Technologies Inc夜盘上涨41.29%，减持扰动消化后资金重估产品进展","url":"https://stock-news.laohu8.com/highlight/detail?id=1100103077","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1100103077?lang=zh_cn&edition=full","pubTime":"2026-10-14 08:02","pubTimestamp":1791936166,"startTime":"0","endTime":"0","summary":"10月14日，Liquidia Technologies Inc夜盘上涨41.29%，报37.88美元/股，成交额1.25万美元。消息面上，市场对董事长经由Canaan LP减持的利空反应有所钝化，资金重新聚焦Yutrepia适应症拓展与商业化放量。此前公司董事长Stephen Bloch于10月5日以每股27.13美元出售235477股，套现约640万美元，相关主体持股降至零；但公司基本面方面，Yutrepia已获FDA快速通道资格，用于系统性硬化症相关雷诺现象，且二季度YUTREPIA净销售额约1.704亿美元，环比增长31%，显示市场更关注后续增长兑现。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"减持扰动消化，Liquidia夜盘大涨","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LQDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104097553","title":"异动解读｜Liquidia Technologies Inc盘后上涨31.63%，董事长减持利空后资金回补","url":"https://stock-news.laohu8.com/highlight/detail?id=1104097553","media":"行情直击","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1104097553?lang=zh_cn&edition=full","pubTime":"2026-10-14 05:46","pubTimestamp":1791928017,"startTime":"0","endTime":"0","summary":"10月14日，Liquidia Technologies Inc盘后上涨31.63%，报35.0447美元/股，成交额533.95万美元。最新可见消息面显示，公司此前被列为一周负面股票关注对象，因董事长Stephen Bloch于10月5日经由Canaan LP以每股27.13美元出售235477股，套现约640万美元；该笔交易后Canaan LP持股降至零。Yutrepia此前获FDA快速通道资格，用于系统性硬化症相关雷诺现象，且公司二季度YUTREPIA净销售额约1.704亿美元，环比增长31%。在前期减持消息扰动后，股价盘后大幅反弹，显示市场更关注产品拓展与商业化进展。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"董事长减持利空落地，Liquidia盘后强势反弹","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LQDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190617819","title":"异动解读｜Liquidia盘中上涨9.67%，FDA快速通道资格与商业化放量提振信心","url":"https://stock-news.laohu8.com/highlight/detail?id=1190617819","media":"行情直击","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1190617819?lang=zh_cn&edition=full","pubTime":"2026-10-12 21:31","pubTimestamp":1791811914,"startTime":"0","endTime":"0","summary":"10月12日，Liquidia盘中上涨9.67%，报29.4401美元/股，成交额550.62万美元。消息面上，FDA授予Yutrepia吸入粉末快速通道资格，用于治疗系统性硬化症相关的雷诺现象，拓展了公司在肺动脉高压之外的适应症布局，并有望获得优先审评及更密切的监管沟通。Liquidia Corporation是一家生物制药公司，专注于开发、制造和商业化满足未满足患者需求的产品，目前主要聚焦肺动脉高压治疗，拥有专有的PRINT粒子工程平台。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Liquidia获FDA快速通道，商业化放量提振信心","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LQDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120583044","title":"异动解读｜Liquidia盘中上涨9.07%，Yutrepia再获FDA快速通道资格提振市场信心","url":"https://stock-news.laohu8.com/highlight/detail?id=1120583044","media":"行情直击","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1120583044?lang=zh_cn&edition=full","pubTime":"2026-10-08 22:17","pubTimestamp":1791469023,"startTime":"0","endTime":"0","summary":"10月8日，Liquidia盘中上涨9.07%，报29.1美元/股，成交额3217.11万美元。消息面上，美国FDA授予Yutrepia吸入粉末快速通道资格，用于治疗系统性硬化症相关的雷诺现象，为公司在肺动脉高压之外的适应症拓展提供重要催化。快速通道资格旨在加速严重疾病疗法的开发与审评，有助于Liquidia与FDA更频繁沟通，并可能获得优先审评资格。此外，Yutrepia在第二季度实现净产品销售额约1.704亿美元，环比增长31%，商业化放量延续强劲趋势。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Liquidia获FDA快速通道资格，股价强势上涨","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LQDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100610899","title":"异动解读｜Liquidia Technologies盘中下跌45.41%，专利诉讼败诉重创市场信心","url":"https://stock-news.laohu8.com/highlight/detail?id=1100610899","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1100610899?lang=zh_cn&edition=full","pubTime":"2026-10-01 02:11","pubTimestamp":1790791872,"startTime":"0","endTime":"0","summary":"10月1日，Liquidia Technologies盘中下跌45.41%，报38.69美元/股，成交额3.97亿美元。该裁决意味着Liquidia核心产品YUTREPIA可能面临专利侵权赔偿或上市限制风险，对公司商业化前景构成重大不确定性。此次专利败诉判决直接冲击了市场对其持续放量增长的预期。Liquidia Corporation是一家生物制药公司，专注于肺动脉高压治疗领域，依托专有PRINT粒子工程技术平台进行药物研发与制造。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"专利败诉重创信心，股价盘中跳水","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LQDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192786112","title":"Liquidia公司Re-Warm研究预计2026年10月启动，主要阶段将于2027年2月收官","url":"https://stock-news.laohu8.com/highlight/detail?id=1192786112","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1192786112?lang=zh_cn&edition=full","pubTime":"2026-09-03 19:31","pubTimestamp":1788435071,"startTime":"0","endTime":"0","summary":"Liquidia公司宣布，其Re-Warm研究项目计划于2026年10月正式启动。该研究的主要阶段预计在2027年2月完成。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LQDA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184500619","title":"异动解读｜Liquidia Technologies盘中下跌5.1%，Q2每股收益不及预期延续获利回吐","url":"https://stock-news.laohu8.com/highlight/detail?id=1184500619","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1184500619?lang=zh_cn&edition=full","pubTime":"2026-08-18 23:03","pubTimestamp":1787065409,"startTime":"0","endTime":"0","summary":"8月18日，Liquidia Technologies盘中下跌5.1%，报73.74美元/股，成交额1996.73万美元，延续财报发布后的回调走势。消息面上，公司于8月12日发布Q2财报，每股收益0.74美元，低于FactSet预期的0.76美元；营收1.717亿美元，同比大幅增长，超出市场预期的1.685亿美元。核心产品YUTREPIA净销售额约1.704亿美元，环比增长31%，独立患者处方数约5,900人。尽管营收端持续放量，但EPS未达部分机构预期，叠加公司股价年内涨幅已超一倍，市场获利回吐情绪持续释放。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LQDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197326088","title":"异动解读｜Liquidia Technologies盘中上涨5.18%，Q2营收大幅超预期下连跌后反弹","url":"https://stock-news.laohu8.com/highlight/detail?id=1197326088","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1197326088?lang=zh_cn&edition=full","pubTime":"2026-08-14 23:03","pubTimestamp":1786719801,"startTime":"0","endTime":"0","summary":"8月14日，Liquidia Technologies盘中上涨5.18%，报75.84美元/股，成交额5809.96万美元。消息面上，公司于8月12日发布Q2财报，营收1.717亿美元同比增长约18.5倍，核心产品YUTREPIA净销售额约1.704亿美元，环比增长31%，独立患者处方数约5,900人，营收超出市场预期的1.685亿美元；但每股收益0.74美元略低于FactSet预期的0.76美元。此前因EPS未达预期叠加年内涨幅已超一倍，股价在前两个交易日累计回调超10%。美银证券此前将公司评级下调至\"中性\"，目标价79美元，当前股价仍低于该目标价水平。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LQDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193199356","title":"异动解读｜Liquidia Technologies盘中下跌5.06%，Q2每股收益不及预期延续获利回吐压力","url":"https://stock-news.laohu8.com/highlight/detail?id=1193199356","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1193199356?lang=zh_cn&edition=full","pubTime":"2026-08-14 01:14","pubTimestamp":1786641293,"startTime":"0","endTime":"0","summary":"8月14日，Liquidia Technologies盘中下跌5.06%，报74.8美元/股，成交额1.46亿美元，延续前一交易日跌势。消息面上，公司于8月12日盘前发布第二季度财报，Q2每股收益为0.74美元，低于FactSet预期的0.76美元；营收1.717亿美元，同比增长约18.5倍，核心产品YUTREPIA净销售额约1.704亿美元，环比增长31%，独立患者处方数约5,900人，营收超出市场一致预期的1.685亿美元。尽管营收端表现亮眼，但EPS未达部分机构预期，叠加此前公司股价年内涨幅已超一倍，市场获利回吐情绪浓厚。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LQDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146449266","title":"异动解读 | Liquidia Technologies盘中大跌5.81%，Q2每股收益不及预期引发获利回吐","url":"https://stock-news.laohu8.com/highlight/detail?id=1146449266","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1146449266?lang=zh_cn&edition=full","pubTime":"2026-08-13 00:40","pubTimestamp":1786552857,"startTime":"0","endTime":"0","summary":"Liquidia Technologies Inc（LQDA）今日盘中大幅下挫5.81%，引发市场广泛关注。消息面上，公司于盘前发布第二季度财报。尽管营收同比增长约18.5倍至17.17亿美元，核心产品YUTREPIA净销售额达17.04亿美元，均超出市场预期，但每股收益为0.74美元，低于FactSet预期的0.76美元及LSEG汇总的0.7722美元预期。净利润亦未达部分分析师预测。此前公司股价年内涨幅已超过一倍，市场已充分消化高增长预期。在EPS不及预期的情况下，投资者选择获利了结。此外，美银证券此前已将公司评级从“买入”下调至“中性”，目标价定为79美元，这对市场情绪形成进一步压制。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["LQDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165651871","title":"异动解读｜Liquidia Technologies盘中下跌5.12%，Q2业绩高增但EPS未达部分机构预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1165651871","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1165651871?lang=zh_cn&edition=full","pubTime":"2026-08-13 00:35","pubTimestamp":1786552525,"startTime":"0","endTime":"0","summary":"8月13日，Liquidia Technologies盘中下跌5.12%，报83.545美元/股，成交额1.39亿美元。消息面上，公司于8月12日盘前发布第二季度财报，Q2实现每股收益0.74美元，较去年同期亏损0.49美元大幅扭亏；营收1.717亿美元，同比增长约18.5倍，核心产品YUTREPIA净销售额约1.704亿美元，环比增长31%，独立患者处方数约5,900人。尽管营收超出市场一致预期的1.685亿美元，但EPS未达FactSet预期的0.76美元，叠加此前股价已充分反映高增长预期，市场出现获利回吐。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LQDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150680357","title":"财报前瞻 ｜Liquidia Technologies Inc本季度营收预计增40.67%，机构观点偏正面","url":"https://stock-news.laohu8.com/highlight/detail?id=1150680357","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1150680357?lang=zh_cn&edition=full","pubTime":"2026-08-05 08:24","pubTimestamp":1785889445,"startTime":"0","endTime":"0","summary":"Liquidia Technologies Inc将于2026年08月12日发布最新季度财报，围绕新一代吸入式治疗产品的放量与商业化推进成为市场关注重点。市场一致预期本季度Liquidia Technologies Inc营收为1.69亿美元，同比增40.67%；预计调整后每股收益为0.74美元，同比增272.32%；预计息税前利润为7,428.59万美元，同比增303.08%。上季度Liquidia Technologies Inc实现营收1.33亿美元，同比增41.58%；毛利率91.08%；归属于母公司股东的净利润为5,286.20万美元，净利率39.79%，调整后每股收益0.52美元，同比增115.56%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻 ｜Liquidia Technologies Inc本季度营收预计增40.67%，机构观点偏正面","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LQDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149333279","title":"异动解读｜Liquidia Technologies盘中上涨5.41%，报88.475美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1149333279","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1149333279?lang=zh_cn&edition=full","pubTime":"2026-08-05 00:17","pubTimestamp":1785860274,"startTime":"0","endTime":"0","summary":"8月5日，Liquidia Technologies盘中上涨5.41%，报88.475美元/股，成交额3513.56万美元。Liquidia Technologies所在的制药行业中，个股中，礼来涨0.49%，辉瑞涨2.18%，阿斯利康跌0.16%，强生跌0.76%，默沙东涨0.74%。Liquidia Corporation是一家生物制药公司，专注于解决未满足患者需求产品的开发、制造和商业化，目前的重点是肺动脉高压的治疗。其核心产品YUTREPIA一季度净产品销售额约1.3亿美元，当季EPS为0.52美元，公司下一次财报预计于8月12日发布，市场预期EPS为0.70美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LQDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127961968","title":"异动解读｜Liquidia Technologies盘前上涨5.57%，报90.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1127961968","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1127961968?lang=zh_cn&edition=full","pubTime":"2026-07-27 19:01","pubTimestamp":1785150085,"startTime":"0","endTime":"0","summary":"7月27日，Liquidia Technologies盘前上涨5.57%，报90.00美元/股，成交额16.06万美元。Liquidia Technologies所在的制药行业中，个股中，礼来涨0.25%，强生涨0%，默沙东跌0.28%，施贵宝涨0.34%，辉瑞涨0.08%。Liquidia Corporation是一家生物制药公司，专注于解决未满足患者需求产品的开发、制造和商业化，目前的重点是肺动脉高压的治疗。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LQDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181056163","title":"异动解读｜Liquidia盘中上涨6.8%，报86.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1181056163","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1181056163?lang=zh_cn&edition=full","pubTime":"2026-07-22 23:39","pubTimestamp":1784734753,"startTime":"0","endTime":"0","summary":"7月22日，Liquidia盘中上涨6.8%，报86.25美元/股，成交额5282.27万美元。Liquidia所在的制药行业中，个股中，礼来跌0.8%，强生涨1.96%，默沙东涨1.83%，辉瑞涨0.48%，诺和诺德跌1.27%。Liquidia Corporation是一家生物制药公司，专注于解决未满足患者需求产品的开发、制造和商业化，目前的重点是肺动脉高压的治疗。该公司通过应用心肺疾病方面的专业知识和专有的PRINT技术进行新产品的研究、开发和制造。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LQDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184282530","title":"异动解读｜Liquidia盘中上涨5.05%，报79.07美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1184282530","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1184282530?lang=zh_cn&edition=full","pubTime":"2026-07-18 01:03","pubTimestamp":1784307828,"startTime":"0","endTime":"0","summary":"7月18日，Liquidia盘中上涨5.05%，报79.07美元/股，成交额4194.29万美元。Liquidia所在的制药行业中，整体表现偏强，个股中，礼来涨0.84%，强生涨1.23%，默沙东涨0.25%，辉瑞跌0.12%，施贵宝涨0.83%。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LQDA"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.liquidia.com","stockEarnings":[{"period":"1week","weight":0.2416},{"period":"1month","weight":-0.3681},{"period":"3month","weight":-0.5053},{"period":"6month","weight":0.1431},{"period":"1year","weight":0.9369},{"period":"ytd","weight":0.2366}],"compareEarnings":[{"period":"1week","weight":-0.0043},{"period":"1month","weight":-0.0102},{"period":"3month","weight":0.0285},{"period":"6month","weight":0.0645},{"period":"1year","weight":0.1313},{"period":"ytd","weight":0.1145}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Liquidia Corporation于2020年6月17日在特拉华州成立。该公司是一家生物制药公司，专注于解决未满足患者需求产品的开发、制造和商业化，目前的重点是肺动脉高压的治疗。该公司通过两家全资子公司Liquidia Technologies和Liquidia PAH作为单一实体运营。该公司通过应用心肺疾病方面的专业知识和专有的PRINT技术进行新产品的研究、开发和制造，PRINT技术是一种粒子工程平台，能够精确生产均匀的药物颗粒，旨在提高广泛疗法的安全性、有效性和性能。通过与第三方的产品开发和研究，该公司拥有将PRINT应用于多种给药途径和药物有效载荷的经验，包括吸入疗法、疫苗、生物制剂、核酸和眼科植入物等。","yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":0.081499},{"month":2,"riseRate":0.75,"avgChangeRate":0.042796},{"month":3,"riseRate":0.5,"avgChangeRate":-0.012167},{"month":4,"riseRate":0.375,"avgChangeRate":-0.058158},{"month":5,"riseRate":0.875,"avgChangeRate":0.19539},{"month":6,"riseRate":0.25,"avgChangeRate":-0.029487},{"month":7,"riseRate":0.375,"avgChangeRate":0.004032},{"month":8,"riseRate":0.444444,"avgChangeRate":0.021851},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.017529},{"month":10,"riseRate":0.666667,"avgChangeRate":0.068513},{"month":11,"riseRate":0.75,"avgChangeRate":0.074904},{"month":12,"riseRate":0.75,"avgChangeRate":0.150821}],"exchange":"NASDAQ","name":"Liquidia Technologies Inc","nameEN":"Liquidia Technologies Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Liquidia Technologies Inc(LQDA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Liquidia Technologies Inc(LQDA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Liquidia Technologies Inc,LQDA,Liquidia Technologies Inc股票,Liquidia Technologies Inc股票老虎,Liquidia Technologies Inc股票老虎国际,Liquidia Technologies Inc行情,Liquidia Technologies Inc股票行情,Liquidia Technologies Inc股价,Liquidia Technologies Inc股市,Liquidia Technologies Inc股票价格,Liquidia Technologies Inc股票交易,Liquidia Technologies Inc股票购买,Liquidia Technologies Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Liquidia Technologies Inc(LQDA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Liquidia Technologies Inc(LQDA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}